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MIGRAINE – PATHOPHYSIOLOGY OF PAIN 
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Summary
Migraine is a primary episodic headache disorder characterized by a cascade of 
events that involve various combinations of neurologic, gastrointestinal and autonomic 
changes. Headache is probably caused by activation of meningeal and blood vessel 
nociceptors combined with an alteration in central pain modulation. Headache and its 
associated neuro-vascular changes are subserved by the trigeminal system. A link also 
exists between the migraine aura and headache. Cortical spreading depression (CSD) 
activates trigeminovascular afferents, causing a long-lasting increase in middle menin-
geal arterial blood flow and polypeptide release within the dura mater. The neuropep-
tides interact with the blood vessel wall, producing dilatation, plasma protein extravasa-
tion, and platelet activation. Neurogenic inflammation sensitizes nerve fibers (peripheral 
sensitization) that now respond to previously innocuous st imuli, such as blood vessel 
pulsations, causing, in part, the pain of migraine.
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IntroductIon 
Migraine is a disabling neurologic disorder that affects more than 10% of 
the adult  population [1]. Migraine is characterized by headache and associated 
symptoms. Typical attacks are characterized by severe, throbbing head pain; 
sensitivity to light (photophobia); sensitivity to sound (phonophobia); and/or ex-
acerbation of pain by head movement; nausea and vomiting also occur in major-
ity of patients [2].Approximately a quarter of patients also has vertigo associated 
with migraine [3]. 
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There are 2 major subtypes of migraine [4]. The most common is migraine 
without aura, accounting for around 75% of cases. The second major subtype is 
migraine with aura, which occurs in approximately 25% of cases [5]. Migraine 
aura is defined as a focal, fully reversible neurological disturbance of relatively 
short duration (<60 minutes) that usualy precedes or accompanies the headache 
and manifests itself as visual, sensory or motor symptoms [6]. It is observed in 
30% of migraine patients, and it is clearly neuraly driven. The hypothesis that 
the aura is the human equivalent of CSD has been well established [7]. Some 
data show that migraine with aura may be associated with vertebral artery hy-
poplasia [8]. 
GenetIc mechanIsm of mIGraIne
Over the past 15 years there has been enormous scientific and clinical prog-
ress in the field of headache. Is is beleived that migraine attacks are caused by 
environmental factors (70%) and genetic factors (30%). Understanding of the ge-
netics of migraine has advanced quickly, due primarily to findings relating to 
the rare, dominantly inherited sub-form called familial hemiplegics migraine 
(FHM). Three genes have now been identified in which mutations can cause 
FHM, as discussed in the article by Moskowitz and co-workers. The CACNA1A 
gene is located on chromosome 19 and encodes the [alpha]1 subunit of a voltage-
dependent calcium channel of the P/Q type; the type of FHM caused by muta-
tion of this gene is now called FHM-1. The next type (FHM-2) is caused by muta-
tion of the ATP1A2 gene on chromosome 1, which encodes the [alpha]2 subunit 
of the sodium–potassium pump. The third gene encodes a voltage-dependent 
sodium channel, IA (mutation leads to FHM-3). There is evidence of yet more 
genetic mechanisms of FHM, since not all families with this disorder link to the 
three demonstrated loci. The fact that all three gene products are involved in the 
regulation of ion homeostasis has led to the suggestion that all migraine may be 
caused by disturbed ion homeostasis. So far, however, no genes have been dem-
onstrated for the more common types of migraine: migraine with typical aura 
and migraine without aura [9]. Therefore, the treatment for various subtypes of 
migraine is recommended [10]. 
cortIcal spreadInG depressIon
Although the first neurologic event in migraine is still a point of controversy, 
it is recognized that migraine arises from primary dysfunction of the central 
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nervous system occurring in the brain and/or the brainstem, which leads to acti-
vation and further sensitization of the trigeminal system (TGS) [4]. Activation of 
the TGS can cause pain and central sensitization directly and it may also induce 
extracephalic vascular inflammation, which may further contribute to the pain. 
Even though what causes the activation of the TGS is still not fully understood, 
it is now generally recognized that migraine arises from a primary brain and/
or brainstem dysfunction [4]. Two neurologic events have been proposed to ac-
count for the origination of migraine: cortical spreading depression (CSD) and 
brainstem dysfunctions.
CSD is a wave of sustained cortical neuronal depolarization followed by 
potent, relatively long-lasting neural suppression. CSD slowly propagates (2-6 
mm/min) over the cortex. The short depolarization phase is associated with an 
increase in regional cerebral blood flow, whereas the phase of reduced neural ac-
tivity is associated with a reduction in cerebral blood flow [4,11]. It is important 
to emphasize that the changes in the blood flow are secondary to the changes in 
neuronal activity.
CSD is likely the physiologic correlate of human migraine aura [2,4] and 
could be key to the initiation of migraine in humans. In humans, CSD could 
arise as a result of the hyperexcitability of the cortex of susceptible patients [11].
The primary cause of a migraine attack was proposed to be an  episodic dys-
function in brainstem nuclei involved in the central control of nociception [11]. 
Brainstem dysfunctions could directly activate the TGS or exert a permissive 
role to facilitate the activation of the TGS [11].
CSD and brainstem dysfunctions are 2 fundamental physiologic events that 
could interact with each other to initiate migraine [11]. CSD may activate the 
TGS, whereas activation of the brainstem may lower the threshold of the brain 
and predispose patients to CSD.
hIGher order processInG/ central modulatInG
of trIGemInal paIn
Following transmission in the caudal brain stem and high cervical spinal 
cord, information is relayed rostrally. Processing of vascular nociceptive signals 
in the thalamus occurs in the ventroposteromedial thalamus , medial nucleus 
of the posterior complex and in the intralaminar thalamus. Zagami and Goads-
by have shown, by application of capsaicin to the superior sagittal sinus, that 
trigeminal projections with a high degree of nociceptive input are processed in 
neurons particulary in the VPM thalamus and its ventral periphery [12].
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These VPM neurons can be modulated by activation of γ-aminobutryc acid 
(GABA) inhibitory receptors and by propranolol but with β1- adrenoceptor 
mechanism [13].
Functional brain imaging with positron emission tomography (PET) in hu-
mans has shown activation of the dorsal midbrain, including the periacqueduc-
tal grey (PAG) and the dorsal pons close to the locus coeruleus, in studies during 
migraine without aura [14]. Dorsolateral pontine activation is observed with PET 
in spontaneus episodic [15] and chronic [16] migraine and with nitrogylcerine 
triggered attacks [17].
neuropeptIde release and mIGraIne
In the past, the “vascular theory of migraine” proposed that transient isch-
emia induced by vasoconstriction was the cause of the symptoms of migraine 
aura, whereas the headache pain reflected rebound abnormal vasodilation and 
mechanical activation of perivascular TGS nerve endings [6]. The vascular theo-
ry, which linked migraine headache pain and vasodilation, is not supported by 
experimental data [4].
For instance, functional brain imaging during migraine with aura demon-
strated that headache pain can start when cerebral blood flow remains decreased 
– that is, when blood vessels are constricted. Conversely, headache sometimes 
disappears even though cerebral blood flow remains increased [18]. Likewise, 
pharmacologic experiments demonstrated that migraine can be induced with-
out dilation of the middle cerebral artery and that profound vasodilation of cra-
nial arteries can fail to trigger migraine attacks. Furthermore, an increase in 
diameter of the middle cerebral artery during migraine attacks could not be 
demonstrated [11].
These data show that the vascular theory is untenable [4].  Many researchers 
now believe that change in vascular tone is a secondary phenomenon, not a pri-
mary cause of migraine and headache pain. Therefore nowadays, the neurovas-
cular theory is propsed as the explanation for all known chemical and vascular 
events that occur during migraine attack. 
An important event in migraine is the release of neuropeptides. Trigemi-
nal sensory neurons contain substance P (SP), calcitonin gene-related peptide 
(CGRP), and neurokinin A. Stimulation of the trigeminal sensory neurons causes 
the release of SP and CGRP from sensory C-fiber terminals and the start of neu-
ro-genic inflammation, suggested by one study to occur in humans [19,20]. IV 
administration of CGRP causes headache and migraine in migraineurs, suggest-
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ing that the increase in CGRP observed during spontaneous migraine attacks 
may play a causative role. Almost all SP-positive trigeminal ganglion neurons 
contain CGRP, whereas more than half of the CGRP-positive neurons are not 
SP-positive, suggesting that SP is always co-released with CGRP. SP is contained 
predominantly in small-diameter sensory C-fibers, whereas CGRP is contained 
in both small- and larger-diameter neurons (corresponding presumably to C- 
and A8-fibers, respectively). A8-fibers are activated at lower stimulus intensities 
than C-fibers I and, when activated, release only CGRP, whereas activation at 
higher intensities activates both A8-J and C-fibers, resulting in the release of 
both CGRP and neurokinins [21,22].
In the cat, trigeminal ganglion stimulation also increases cerebral blood 
flow by a pathway traversing the greater superficial petrosal branch of the facial 
nerve releasing a powerful vasodilator peptide, vasoactive intestinal polypep-
tide (VIP) [23]. Stimulation of the more specifically vascular pain producing su-
perior sagittal sinus increases cerebral blood flow and jugular vein CGRP level.
According to this neurogenic inflammation theory, ions and inflammatory 
agents are released in the vicinity of sensory fibers innervating the meninges, 
where they activate and sensitize peripheral nociceptors [24,25]. This cascade 
of events is character ized by vasodilatation, plasma protein extravasation, and 
the release of pro-inflammatory mediators such as bradykinin, prostanoids, and 
protons.
Exposure of perivascular fibers to chemical agents alters their sensitivity to 
subsequent stimuli and leads to the sensation of  head pain [26]. The cause of the 
initial release of these chemicals has not been established but may arise from 
brain, within blood, or from meningeal tissues.
Evidence from humans that CGRP level is elevated in the headache phase 
of migraine [27], cluster headache [28] and chronic paroxysmal hemicrania [29] 
supports the vieww that the trigeminovascular system might be activated for 
a protective role in these conditions. Moreover, NO-donor-triggered migraine, 
which is the typical form of migraine, also results in increased levels of CGRP 
that are inhibited by sumatriptan, as in spontaneous migraine.
sensItIsatIon and allodynIa
Patients desribe various sensations of pain. The pain may be diffuse with 
a dull, burning quality and may move, radiate or spread through different in-
nervation territories. Patients with migraine usually report pain that involves 
the front of the head, in the cutaneus distribution of the first (ophtalmic) branch 
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of the trigeminal nerve. However, pain from the back of the head, innervated 
by great occipital nerve, which is a branch of C2 spinal root, is also described 
[30,31].
The term sensitisation reffers to increased afferent activity for an unchanged 
stimulus. For an example, activation of C fibers by heat or chemical stimulation 
would produce sensitisation.
Sensitisation may occur in three primary ways: 
1) Peripheral sensitisation which  implies increased primary afferent activity 
from an unchanged stimulus due to some local activating process, 
2) Central sensitisation and
3) Disinhibitory sensitisation
In recent years it has become apparent that many types of prolonged or 
chronic pain are associated with long-lasting activation and sensitization of 
peripheral nociceptors and/or central nociceptive neurons in the dorsal horn. 
By incorporating these concepts into basic research on migraine pathophysiol-
ogy, a new animal model for long-lasting headache of migraine was developed. 
This model involves prolonged activation and subsequent sensitization of the 
trigeminovascular system in response to a brief exposure of the dura to a mix-
ture of inflammatory agents consisting of serotonin (5-HT), bradykinin, hista-
mine, and prostaglandin (PG) [26]. These agents activate and sensitize somatic 
and visceral nociceptors in the rat and are potent algesics in humans, capable of 
inducing headache [32]. With this animal model, it was found that a brief chemi-
cal irritation of the dura activates and sensitizes meningeal nociceptors over a 
long period of time, rendering them responsive to me chanical stimuli to which 
they showed only minimal or no response before their sensitization. During mi-
graine, such peripheral sensitization is likely to mediate the throbbing pain and 
its aggravation during routine physical activities.
Brief stimulation of the dura with inflammatory agents also activates and 
sensitizes second-order trigeminovascular neurons located in the spinal trigem-
inal nucleus that receive convergent input from the dura and the skin [24]. In 
this paradigm, the central trigeminovascular neurons develop hypersensitivity 
in the periorbital skin, manifested as increased responsiveness to mild stimuli 
(brush, heat, cold) to which they showed only minimal or no response be fore 
their sensitization. The induction of central sen sitization by intracranial stimu-
lation of the dura and the ensuing extracranial hypersensitivity were taken to 
suggest that a similar process occurs in patients, during migraine.
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Therefore the current view is that extracranial hypersensitivity is a manifesta-
tion of central neuronal sensitization. Recent quantitative stimulation applied to the 
surface of the skin showed that pain thresholds to mechanical, heat, and cold skin 
stimuli decrease significantly during migraine in the majority of patients. This skin 
hypersensitivity, termed cutane ous allodynia, is typically found in the periorbital 
area on the side of the migraine headache. Patients commonly notice cutaneous al-
lodynia during mi graine when they become irritated by innocuous activities such 
as combing, shaving, taking a shower, wearing eyeglasses or earrings, or resting 
the head on a pillow on the headache side. Ipsilateral cephalic allodynia is likely to 
be mediated by sensitization of trigeminovascular neurons in the spinal trigeminal 
nucleus that process sensory inputs from dura and periorbital skin.
Allthough all molecular mechanisms involeved in the migraine attack are 
not fully understood, unravelling the physiology and pharmacology of migraine 
and searching for its basic molecular mechanisms will provide new treatments 
for this disabling headache.
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Sažetak
Migrena – patofiziologija boli
Migrena je primarna glavobolja epizodnog karaktera karakterizirana nizom događaja koji 
uključuju kombinacije neuroloških, gastrointestinalnih i autonomnih promjena. Glavobolja je 
vjerojatno uzrokovana aktivacijom nociceptora u meningama i u stjenci krvnih žila, u kom-
binaciji s poremećajem u centralnoj modulaciji boli. Glavobolja i pridružene neurovaskularne 
promjene povezane su s trigeminalnim sustavom. Postoji također veza između migrenske aure 
i glavobolje. Kortikalna šireća depresija aktivira trigeminovaskularna aferentna vlakna, uslijed 
čega dolazi do dugotrajnog porasta protoka u srednjoj meningealnoj arteriji kao i u otpuštanju 
polipeptida unutar dure. Uslijed interakcije neuropeptida i stijenke krvne žile dolazi do dilatacije, 
ekstravazacije proteina plazme te aktivacije trombocita. Upala senzitizira živčana vlakna (peri-
ferna senzitizacija) te oni sad reagiraju na prethodno bezazlen podražaj, npr. pulzacije krvne 
žile, uzrokujući, barem djelomično, migrensku bol.
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